SVATHI REDDY: Open Payments
NPI 1528179124 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 35 payments from 7 companies in 2025. Trend: 2023 $500 · 2024 $604 · 2025 $761
Food & beverage: $761
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 13 | $246 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $102 |
| Teva Pharmaceuticals USA, Inc. | 4 | $98 |
| ABBVIE INC. | 4 | $97 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Lundbeck LLC | 3 | $65 |
Products named: INGREZZA, REXULTI, CAPLYTA, AUSTEDO XR, VRAYLAR, Auvelity.
Industry payments across GA — which companies pay providers there.
